Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Home / Biotech firm Propanc secures $100m for digital asset acquisition
Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Ark Invest has added more shares of Coinbase and Robinhood across its exchange-traded funds on Tuesday as crypto equities dipped
Vitalik Buterin has sparked debate within the crypto community after outlining a vision for Ethereum as part of a broader
AAVE price remains at risk of a crash as a major delegator and service provider, the Aave Chan Initiative, has